Japan Cytomegalovirus (CMV) Infection Epidemiology Insights 2017-2023 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cytomegalovirus (CMV) Infection - Epidemiology Insights - 2023 - Japan" report to their offering.

This report provides an overview of the disease and the historical and forecasted epidemiological data of Cytomegalovirus (CMV) Infection in Japan for 2013 - 2023. The report considers the transplant patients, HIV patients and Infants under high risk for CMV infections and epidemiology forecasts for these high risk categories have also been taken into consideration.

According to experts, the total number of Diagnosed Cytomegalovirus (CMV) Infection cases is expected to increase at a CAGR of 0.056% to 7,355 cases in 2023. Out of all these high risk categories, Infants have comparatively higher numbers of CMV prevalent cases than HIV and Transplant patients in Japan.

Scope:

  • Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis and disease management.
  • Identifying patient populations in the Japan Cytomegalovirus (CMV) Infection market
  • The Report covers the historical and forecasted epidemiological data covering Japan from 2013 - 2023.

Key Topics Covered:

  1. Disease Overview
  2. Symptoms of cytomegalovirus (CMV) Infection
  3. Etiology
  4. Risk Factors
  5. Pathogenesis of human cytomegalovirus
  6. Pathophysiology of cytomegalovirus infection
  7. Epidemiology and Patient Population
  8. Total CMV Prevalent, Diagnosed and Treatable Cases: Historical Data (2013-2015)
  9. Total CMV Prevalent, Diagnosed and Treatable Cases: Forecasted Data (2016-2023)
  10. CMV Patients among Transplants: Historical Data (2013-2015)
  11. CMV Patients among Transplants: Forecasted Data (2016-2023)
  12. Infant Patients at High Risk of CMV: Historical Data (2013-2015)
  13. Infant Patients at High Risk of CMV: Forecasted Data (2016-2023)
  14. HIV Patients at High Risk of CMV: Historical Data (2013-2015)
  15. HIV Patients at High Risk of CMV: Forecasted Data (2016-2023)
  16. Unmet Medical Needs
  17. Assumptions and Rationale
  18. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/k22lwd/cytomegalovirus

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs